BioMedNewsBreaks – RYAH Group Inc. Bringing Innovative Tech Solutions to Plant-Based Treatment Market

RYAH Group, a company developing proprietary technology supporting a data-driven approach to health care, understands the value of combining data with analytics, as reflected by the fact that its products merge these two fundamental elements. “The company has created unique products that pair a growing ecosystem of therapeutic plants with top-rated apps, devices and services,” reads a recent article. “RYAH’s easy-to-operate line of products help foster a seamless dose-control experience that generates insightful data, making it simple for doctors, researchers and end-users to hone in on the ideal settings for the best possible treatment outcomes with RYAH Smart Patch, RYAH Smart Inhaler, RYAH Smart Pen and upcoming RYAH MD platform. These proprietary IoT devices and data analytics are supported by patented AI technology to aggregate and correlate HIPAA-compliant dosing data from seed to consumption.”

To view the full article, visit https://ibn.fm/MDjiH

RYAH Group Inc.

RYAH is a company operating out of New York, which, directly and through its wholly owned subsidiary RYAH Medtech Inc., is engaged in the development and commercialization of various innovative technology solutions (both software and hardware) for the plant-based medical industry. Since its formation, RYAH Group has been focused on leveraging its know-how in predictive analytics to pioneer products to be used within its suite of vertically integrated technologies to provide users with added control over their health and wellness. As an emerging company, RYAH is striving to establish itself as a leader in delivering innovative, user-friendly IoT devices in the plant-based medical industry. By utilizing its know-how in fields such as artificial intelligence and predictive analytics, the company is moving towards building a portfolio of vertically integrated products that facilitate harmonized data collection throughout the complete medical plant lifecycle, from seed to consumption. For more information about the company, please visit www.RYAHGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to RYAH Group are available in the company’s newsroom at https://ibn.fm/RYAH

About BioMedWire

BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork